CnogaCare operates in the healthcare technology sector, specializing in telemedicine and remote patient monitoring solutions. The company serves healthcare providers, including hospitals, clinics, and general practitioners, with a focus on enhancing patient care through advanced technology. CnogaCare's core products include non-invasive diagnostic devices and wearable technology that monitor vital signs and other health parameters. The company is particularly noted for its MTX multi-parameter mini monitor, which has been instrumental in remote monitoring projects, such as the Talisman project in the Puglia region of Italy. This project demonstrated the effectiveness of remote monitoring for COVID-19 patients quarantined at home, and the technology is now used for general home care monitoring. CnogaCare's business model revolves around selling these innovative devices and offering subscription-based remote monitoring services. Revenue is generated through direct sales to healthcare institutions and ongoing service fees for monitoring solutions. The company operates in a growing market driven by the increasing demand for telemedicine and remote healthcare solutions, particularly in the wake of the COVID-19 pandemic.

Keywords: telemedicine, remote monitoring, non-invasive diagnostics, healthcare technology, wearable devices, MTX monitor, COVID-19, home care, patient care, subscription services.